Prostate cancer imaging: what the urologist wants to know.
Radiol Clin North Am
; 50(6): 1015-41, 2012 Nov.
Article
en En
| MEDLINE
| ID: mdl-23122036
ABSTRACT
No consensus exists at present regarding the use of imaging for the evaluation of prostate cancer. Ultrasonography is mainly used for biopsy guidance and magnetic resonance imaging is the mainstay in evaluating the extent of local tumor. Computed tomography and radionuclide bone scanning are mainly reserved for assessment of advanced disease. Positron emission tomography is gaining acceptance in the evaluation of treatment response and recurrence. The combination of anatomic, functional, and metabolic imaging modalities has promise to improve treatment. This article reviews current imaging techniques and touches on the evolving technologies being used for detection and follow-up of prostate cancer.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neoplasias de la Próstata
/
Urología
/
Diagnóstico por Imagen
Tipo de estudio:
Diagnostic_studies
/
Guideline
Límite:
Humans
/
Male
Idioma:
En
Revista:
Radiol Clin North Am
Año:
2012
Tipo del documento:
Article
País de afiliación:
Estados Unidos